131 related articles for article (PubMed ID: 6297730)
1. Phase II clinical study of Yoshi 864 in squamous cell carcinoma of the uterine cervix.
Slavik M; Muss H; Blessing JA
Cancer Treat Rep; 1983 Feb; 67(2):195-6. PubMed ID: 6297730
[No Abstract] [Full Text] [Related]
2. Phase II trial of AMSA in patients with advanced or recurrent squamous cell carcinoma of the cervix: a gynecologic oncology group study.
Bonomi P; Blessing JA; Sedlacek TV; Homesley HD; DiSaia PJ
Cancer Treat Rep; 1983 Feb; 67(2):197-8. PubMed ID: 6687445
[No Abstract] [Full Text] [Related]
3. Phase II clinical trial of diaziquone in the treatment of patients with recurrent squamous cell carcinoma of the cervix: a Gynecologic Oncology Group Study.
Slayton RE; Blessing JA; Stehman FB; Malfetano J
Cancer Treat Rep; 1986 Sep; 70(9):1127-8. PubMed ID: 3742494
[No Abstract] [Full Text] [Related]
4. Teniposide in squamous cell carcinoma of the cervix: a phase II trial of the Gynecologic Oncology Group.
Muss HB; Bundy BN; Yazigi R; Yordan E
Cancer Treat Rep; 1987 Sep; 71(9):873-4. PubMed ID: 3621222
[No Abstract] [Full Text] [Related]
5. [Healing apparent 5 years after chemotherapy for cervix epidermoid carcinoma in advanced phase].
Amalric R; Ayme Y; Desgeorge Y; Spitalier JM
Mars Med; 1967; 104(12):1081-3. PubMed ID: 5623526
[No Abstract] [Full Text] [Related]
6. Phase II trial of dichloromethotrexate in patients with advanced squamous cell carcinoma of the cervix: a Gynecologic Oncology Group Study.
Roberts JA; Blessing JA; McGehee R; Beecham J; Homesley HD
Cancer Treat Rep; 1987 Dec; 71(12):1295-6. PubMed ID: 3690541
[No Abstract] [Full Text] [Related]
7. Phase II randomized study of doxorubicin, vincristine, and 5-FU versus cyclophosphamide in advanced squamous cell carcinoma of the cervix.
Omura GA; Vélez-García E; Birch R
Cancer Treat Rep; 1981; 65(9-10):901-3. PubMed ID: 7196801
[TBL] [Abstract][Full Text] [Related]
8. Phase II trial of etoposide in the management of advanced or recurrent non-squamous cell carcinoma of the cervix: a Gynecologic Oncology Group study.
Slayton RE; Blessing JA; Homesley HD
Cancer Treat Rep; 1984 Dec; 68(12):1513-4. PubMed ID: 6509456
[No Abstract] [Full Text] [Related]
9. Phase II study of spirogermanium in patients with advanced carcinoma of the cervix.
Brenner DE; Rosenshein NB; Dillon M; Jones HW; Forastiere A; Tipping S; Burnett LS; Greco FA; Wiernik PH
Cancer Treat Rep; 1985 Apr; 69(4):457-8. PubMed ID: 3995514
[No Abstract] [Full Text] [Related]
10. Topotecan in squamous cell carcinoma of the cervix: A Phase II study of the Gynecologic Oncology Group.
Bookman MA; Blessing JA; Hanjani P; Herzog TJ; Andersen WA
Gynecol Oncol; 2000 Jun; 77(3):446-9. PubMed ID: 10831357
[TBL] [Abstract][Full Text] [Related]
11. Treatment of disseminated squamous cell carcinoma of the cervix.
Reed ML
J Am Osteopath Assoc; 1971 Aug; 70(12):1331-2. PubMed ID: 5209204
[No Abstract] [Full Text] [Related]
12. Continuous-infusion vindesine in refractory carcinoma of the cervix: a phase II trial.
Kavanagh JJ; Saul PB; Gershenson DM; Copeland LJ; Wharton JT
Cancer Treat Rep; 1985 Nov; 69(11):1317-8. PubMed ID: 4092193
[No Abstract] [Full Text] [Related]
13. [Phase II study of 5-FU tablets in cancer of the uterine cervix].
Sekiba K; Yajima A; Tenjin Y; Kurihara S; Akiya K; Okada K; Noda K; Ozaki M; Hasegawa K; Mori T
Gan To Kagaku Ryoho; 1987 Jul; 14(7):2365-73. PubMed ID: 3606156
[TBL] [Abstract][Full Text] [Related]
14. A Phase II study of topotecan in patients with squamous cell carcinoma of the cervix: a gynecologic oncology group study.
Muderspach LI; Blessing JA; Levenback C; Moore JL
Gynecol Oncol; 2001 May; 81(2):213-5. PubMed ID: 11354055
[TBL] [Abstract][Full Text] [Related]
15. Mitoxantrone and advanced squamous cell carcinoma of the cervix: a Southwest Oncology Group Study.
Hilgers RD; Von Hoff DD; Stephens RL; Boutselis JG
Cancer Treat Rep; 1986 Apr; 70(4):527-8. PubMed ID: 3698047
[No Abstract] [Full Text] [Related]
16. Mitoxantrone in advanced cervical carcinoma: a phase II study in patients not previously treated with chemotherapy.
Hørding U; Rose C; Jakobsen K; Dirksen H
Cancer Treat Rep; 1986 Oct; 70(10):1239-40. PubMed ID: 3756944
[No Abstract] [Full Text] [Related]
17. Phase I trial of concurrent chemoradiation with weekly nedaplatin in patients with squamous cell carcinoma of the uterine cervix.
Yoshinaga K; Niikura H; Ogawa Y; Nemoto K; Nagase S; Takano T; Ito K; Yaegashi N
Gynecol Oncol; 2007 Jan; 104(1):36-40. PubMed ID: 16889822
[TBL] [Abstract][Full Text] [Related]
18. [Alkylating monochemotherapy in the treatment of carcinomas of the uterine cervix and endometrium in advanced phases].
Alberini L; Perego C
Minerva Ginecol; 1982; 34(1-2):99-104. PubMed ID: 7078831
[No Abstract] [Full Text] [Related]
19. Activity of mitolactol in cancer of the uterine cervix.
Lira-Puerto V; Morales-Canfield F; Wernz J; Muggia FM
Cancer Treat Rep; 1984 Apr; 68(4):669-70. PubMed ID: 6713421
[TBL] [Abstract][Full Text] [Related]
20. [Studies on the recording of cytostatic effects on organ cultures of squamous cell carcinoma of the uterine cervix].
Ebeling K; Ruckhäberle KE; Bilek K
Zentralbl Gynakol; 1977; 99(20):1249-59. PubMed ID: 595962
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
